Huike Wang

5PUBLICATIONS
6CO-AUTHORS
Environmental epidemiologySolid tumoursPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 01, 2026
Efficacy and Safety of Everolimus in Advanced Unresectable and Progressive Epithelioid Hemangioendothelioma: A Single-Center Case Series.

|Apr 29, 2026
Camrelizumab Plus Apatinib in Advanced Unresectable Alveolar Soft Part Sarcoma and Undifferentiated Pleomorphic Sarcoma Patients: A Single-Center, Exploratory Case Series.

|Apr 21, 2026
Efficacy and Safety of Anthracyclines Combined with Temozolomide Regimens for the Treatment of Advanced Leiomyosarcoma: A Retrospective Study.

|Apr 12, 2023
A Novel Predictor of Pathologic Complete Response for Neoadjuvant Immunochemotherapy in Resectable Locally Advanced Esophageal Squamous Cell Carcinoma.

Yalan Yang, Dao Xin, Huike Wang

|Jan 28, 2023
Clinical usefulness of the lymphocyte-to-monocyte ratio and aggregate index of systemic inflammation in patients with esophageal cancer: a retrospective cohort study.

Hui-Ke Wang, Qian Wei, Ya-Lan Yang

Pageof 1

Frequent Collaborators

2 joint publications

Yalan Yang

2 joint publications

Feng Wang

2 joint publications

Susheng Shi

1 joint publications

Qian Wei